Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes

Tekijä Dei Cas, Alessandra, Spigoni, Valentina, Cito, Monia, Aldigeri, Raffaella, Ridolfi, Valentina, Marchesi, Elisabetta, Marina, Michela, Derlindati, Eleonora, Aloe, Rosalia, Bonadonna, Riccardo C., Zavaroni, Ivana
Julkaisussa Cardiovasc Diabetol (2017)